ERISA Ledger · U.S. DOL EBSA Form 5500 (2024)

Ligand Pharmaceuticals INC.

Official 2024 U.S. DOL Form 5500 summary for Ligand Pharmaceuticals INC. (Ligand Pharmaceuticals INC. 401(k) Plan · EIN 77-0160744 · PN 001): $28.89M net assets, 69 active participants, and $0.59 per $10,000 (0.59 bps).

Reported Form 5500 Fee & Service Summary

Plan SponsorLigand Pharmaceuticals INC.
Filing IdentifierLigand Pharmaceuticals INC. 401(k) Plan · EIN 77-0160744 · PN 001
Plan Category & State401(k) Defined Contribution (CA)
Asset-Size Peer Cohort$25M-$100M
Plan Net Assets (2024)$28.89M
Active Participants69
Direct Admin Fee Rate$0.59 per $10,000 (0.59 bps)
Cohort Peer Median$19.23 per $10,000 (19.23 bps)
Primary Recordkeeper / ProviderFidelity Investments
Schedule H Line 4a RemittanceTimely Employer Remittance (0 reported on Line 4a)

Browse all 78,373 plans & Schedule C vendors · Methodology · Meru AI